Corporate News 06-Jun-17
Vivimed Labs intimates of successful USFDA inspection of its API facility in Spain
Receives 'zero' 483 observations
Vivimed Labs announced that the Company's API manufacturing facility located in Sant Celoni, Spain was recently inspected by the USFDA in compliance with their requirements. At the end of the successful inspection, 'zero' 483 observations were issued.
Previous News
Vivimed Labs reports standalone net loss of Rs 23.63 crore in the December 2021 quarter
( Results - Announcements 15-Feb-22 08:14 )
Vivimed Labs to discuss results
( Corporate News - 03-Aug-21 13:19 )
Vivimed Labs AGM scheduled
( Corporate News - 16-Aug-19 17:16 )
Vivimed Labs reports consolidated net loss of Rs 23.30 crore in the September 2021 quarter
( Results - Announcements 14-Nov-21 09:28 )
Vivimed Labs Ltd leads gainers in 'B' group
( Hot Pursuit - 20-Apr-21 12:15 )
Vivimed Labs Ltd leads losers in 'B' group
( Hot Pursuit - 21-Jan-19 14:46 )
Vivimed Labs to hold board meeting
( Corporate News - 04-Sep-21 14:08 )
Vivimed Labs incorporates subsidiary - Vivimed Labs (Mascarene)
( Corporate News - 26-Sep-17 10:16 )
Vivimed Labs to hold AGM
( Corporate News - 05-Dec-20 15:04 )
Vivimed Labs standalone net profit declines 94.81% in the March 2018 quarter
( Results - Announcements 07-Jun-18 17:43 )
Lupin Ltd Slides 4.3%
( Hot Pursuit - 16-May-19 09:45 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
